Has Emily Kastner received payments from drug or device companies?

Yes. Drug and device makers reported $2,350 in general payments to Emily Kastner across 110 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emily Kastner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emily Kastner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emily Kastner

Family · Buffalo, NYNPI 1629563200

Payments from drug & device makers

$2,350in general payments, 2019–2025

Across 110 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$458
AstraZeneca$328
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$281
Pfizer$202
Johnson & Johnson$169
Amgen$125
plus $787 from 15 others

What the payments were for

Food & beverage$2,27597%
Education$753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	21	$458
AstraZeneca	11	$328
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	17	$281
Pfizer	10	$202
Johnson & Johnson	3	$169
Amgen	8	$125
Alnylam Pharmaceuticals Inc.	6	$117
Novartis	7	$113
E.r. Squibb & Sons, L.L.C.	4	$101
Boehringer Ingelheim	5	$85
Daiichi Sankyo Inc.	2	$52
Edwards Lifesciences	2	$50
Bridgebio Pharma, Inc.	2	$46
Regeneron Healthcare Solutions, Inc.	2	$45
Philips North America LLC	2	$42
Bayer	2	$35
Sanofi-aventis U.S. LLC	2	$30
Inspire Medical Systems, Inc.	1	$21
Kiniksa Pharmaceuticals International, PLC	1	$18
Medtronic	1	$16
Boston Scientific	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XARELTO$138
FARXIGA$130

How this compares

$2,350 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	66	$56,884
XareltoRivaroxaban	19	$16,746
FarxigaDapagliflozin Propanediol	19	$10,519
Metoprolol Succinate	54	$1,010
Atorvastatin Calcium	50	$738
Losartan Potassium	44	$588
Ezetimibe	27	$573
Rosuvastatin Calcium	46	$559
Spironolactone-HctzSpironolact/Hydrochlorothiazid	11	$540
Carvedilol	63	$516
Valsartan	12	$511
Olmesartan Medoxomil	17	$373
ClopidogrelClopidogrel Bisulfate	29	$248
Lisinopril	20	$246
Spironolactone	39	$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$202	$56,88466 claims
Johnson & JohnsonXarelto	$169	$16,74619 claims
AstraZenecaFarxiga	$328	$10,51919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in Buffalo

Amy FosterBuffalo$31K
Jessica HongBuffalo$25K
Christina NalboneNew York$197K
Casey GrilloNew York$191K
Suzanne WilsonIthaca$179K
Jonathan LesuerSyracuse$172K
Sheri HillNorth Syracuse$165K
Cathrine CurtinBronxville$155K
Mary Sullivan-WhalenNew York$137K
Sarah AljahmiRockville Centre$87K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →